EU
Emory University Portfolio holdings
AUM
$27.7M
This Quarter Return
+3.88%
1 Year Return
+31.53%
3 Year Return
–
5 Year Return
–
10 Year Return
–
AUM
$151M
AUM Growth
+$151M
(+7.6%)
Cap. Flow
+$12M
Cap. Flow
% of AUM
7.96%
Top 10 Holdings %
Top 10 Hldgs %
48.89%
Holding
53
New
7
Increased
21
Reduced
13
Closed
7
Top Buys
| 1 |
JD.com
JD
|
$10.6M |
| 2 |
Heron Therapeutics
HRTX
|
$3.28M |
| 3 |
ABMD
Abiomed Inc
ABMD
|
$2.89M |
| 4 |
ECYT
Endocyte, Inc. Common Stock
ECYT
|
$2.83M |
| 5 |
TG Therapeutics
TGTX
|
$2.57M |
Top Sells
| 1 |
AVXS
AveXis, Inc. Common Stock
AVXS
|
$2.78M |
| 2 |
Puma Biotechnology
PBYI
|
$2.66M |
| 3 |
ABLX
Ablynx NV American Depositary Shares
ABLX
|
$2.63M |
| 4 |
Travere Therapeutics
TVTX
|
$2.57M |
| 5 |
XLRN
Acceleron Pharma Inc.
XLRN
|
$2.44M |
Sector Composition
| 1 | Healthcare | 47.81% |
| 2 | Financials | 29.15% |
| 3 | Consumer Discretionary | 10.46% |
| 4 | Industrials | 2.95% |
| 5 | Communication Services | 1.9% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
SAGE
26
DELISTED
Sage Therapeutics
SAGE
| $2.43M | 1.61% | 15,495 -637 | -4% | -$99.7K |
|
27
Armstrong World Industries
AWI
$8.47B
| $2.34M | 1.56% | 37,069 +2,831 | +8% | +$179K |
|
28
Iovance Biotherapeutics
IOVA
$807M
| $2.25M | 1.49% | +175,597 | New | +$2.25M |
|
29
CBRE Group
CBRE
$48.2B
| $2.2M | 1.46% | 46,168 -720 | -2% | -$34.4K |
|
|
ONC
30
BeOne Medicines Ltd. American Depositary Shares
ONC
$36.4B
| $2.2M | 1.46% | 14,321 -4,849 | -25% | -$746K |
|
31
Acadia Pharmaceuticals
ACAD
$4.38B
| $2.2M | 1.46% | 144,125 +59,411 | +70% | +$907K |
|
|
DRNA
32
DELISTED
Dicerna Pharmaceuticals, Inc.
DRNA
| $2.2M | 1.46% | 179,568 -66,843 | -27% | -$819K |
|
|
CORI
33
DELISTED
Corium International, Inc.
CORI
| $2.2M | 1.46% | 274,651 +64,092 | +30% | +$513K |
|
34
SLM Corp
SLM
$6.52B
| $2.15M | 1.43% | +187,754 | New | +$2.15M |
|
35
KALA BIO
KALA
$78.8M
| $2.12M | 1.41% | 154,391 -22,951 | -13% | -$315K |
|
36
Seagate
STX
$35.6B
| $2.12M | 1.41% | 37,505 -3,711 | -9% | -$210K |
|
37
Trinity Industries
TRN
$2.3B
| $2.1M | 1.4% | 61,362 +531 | +0.9% | +$18.2K |
|
|
BPMC
38
DELISTED
Blueprint Medicines
BPMC
| $2.1M | 1.39% | 33,101 +938 | +3% | +$59.5K |
|
|
DBVT
39
DBV Technologies
DBVT
$264M
| $2.1M | 1.39% | 108,679 +7,389 | +7% | +$143K |
|
40
Citigroup
C
$178B
| $2M | 1.32% | +29,811 | New | +$2M |
|
41
Morgan Stanley
MS
$240B
| $1.87M | 1.24% | 39,532 +1,066 | +3% | +$50.5K |
|
|
SMC
42
Summit Midstream Corporation
SMC
$282M
| $1.35M | 0.89% | 87,560 | – | – |
|
43
Cocrystal Pharma
COCP
$15.4M
| $560K | 0.37% | 152,916 | – | – |
|
44
Neurogene
NGNE
$264M
| $554K | 0.37% | 209,207 +30,045 | +17% | +$79.6K |
|
45
Amazon
AMZN
$2.44T
| $269K | 0.18% | 158 | – | – |
|
46
SPDR S&P 500 ETF Trust
SPY
$658B
| $237K | 0.16% | 872 | – | – |
|
47
Microsoft
MSFT
$3.77T
| – | – | -23,505 | Closed | -$2.15M |
|
|
48
Puma Biotechnology
PBYI
$254M
| – | – | -39,066 | Closed | -$2.66M |
|
|
49
Travere Therapeutics
TVTX
$1.56B
| – | – | -115,136 | Closed | -$2.57M |
|
|
XLRN
50
DELISTED
Acceleron Pharma Inc.
XLRN
| – | – | -62,410 | Closed | -$2.44M |
|